Global Preventive Vaccines Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Preventive Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Preventive Vaccines market size is USD million in 2022 from USD 53370 million in 2021, with a change of % between 2021 and 2022. The global Preventive Vaccines market size will reach USD 96940 million in 2028, growing at a CAGR of 8.9% over the analysis period.
The United States Preventive Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Preventive Vaccines market, reaching US$ million by the year 2028. As for the Europe Preventive Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Preventive Vaccines players cover Sanofi, AstraZeneca, CSL Ltd, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Preventive Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Preventive Vaccines market size is USD million in 2022 from USD 53370 million in 2021, with a change of % between 2021 and 2022. The global Preventive Vaccines market size will reach USD 96940 million in 2028, growing at a CAGR of 8.9% over the analysis period.
The United States Preventive Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Preventive Vaccines market, reaching US$ million by the year 2028. As for the Europe Preventive Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Preventive Vaccines players cover Sanofi, AstraZeneca, CSL Ltd, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Intramuscular Injection
- Nasal Spray
- Intradermal Shot
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- AstraZeneca
- CSL Ltd
- Abbott
- GlaxoSmithKline
- Serum Institute of India
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventive Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Preventive Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Preventive Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Preventive Vaccines Segment by Type
2.2.1 Intramuscular Injection
2.2.2 Nasal Spray
2.2.3 Intradermal Shot
2.3 Preventive Vaccines Sales by Type
2.3.1 Global Preventive Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Preventive Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Preventive Vaccines Sale Price by Type (2017-2022)
2.4 Preventive Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Preventive Vaccines Sales by Application
2.5.1 Global Preventive Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Preventive Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Preventive Vaccines Sale Price by Application (2017-2022)
3 GLOBAL PREVENTIVE VACCINES BY COMPANY
3.1 Global Preventive Vaccines Breakdown Data by Company
3.1.1 Global Preventive Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Preventive Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Preventive Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Preventive Vaccines Revenue by Company (2020-2022)
3.2.2 Global Preventive Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Preventive Vaccines Sale Price by Company
3.4 Key Manufacturers Preventive Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventive Vaccines Product Location Distribution
3.4.2 Players Preventive Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Preventive Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Preventive Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Preventive Vaccines Annual Revenue by Geographic Region
4.2 World Historic Preventive Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Preventive Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Preventive Vaccines Annual Revenue by Country/Region
4.3 Americas Preventive Vaccines Sales Growth
4.4 APAC Preventive Vaccines Sales Growth
4.5 Europe Preventive Vaccines Sales Growth
4.6 Middle East & Africa Preventive Vaccines Sales Growth
5 AMERICAS
5.1 Americas Preventive Vaccines Sales by Country
5.1.1 Americas Preventive Vaccines Sales by Country (2017-2022)
5.1.2 Americas Preventive Vaccines Revenue by Country (2017-2022)
5.2 Americas Preventive Vaccines Sales by Type
5.3 Americas Preventive Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventive Vaccines Sales by Region
6.1.1 APAC Preventive Vaccines Sales by Region (2017-2022)
6.1.2 APAC Preventive Vaccines Revenue by Region (2017-2022)
6.2 APAC Preventive Vaccines Sales by Type
6.3 APAC Preventive Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventive Vaccines by Country
7.1.1 Europe Preventive Vaccines Sales by Country (2017-2022)
7.1.2 Europe Preventive Vaccines Revenue by Country (2017-2022)
7.2 Europe Preventive Vaccines Sales by Type
7.3 Europe Preventive Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventive Vaccines by Country
8.1.1 Middle East & Africa Preventive Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Preventive Vaccines Sales by Type
8.3 Middle East & Africa Preventive Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventive Vaccines
10.3 Manufacturing Process Analysis of Preventive Vaccines
10.4 Industry Chain Structure of Preventive Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventive Vaccines Distributors
11.3 Preventive Vaccines Customer
12 WORLD FORECAST REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION
12.1 Global Preventive Vaccines Market Size Forecast by Region
12.1.1 Global Preventive Vaccines Forecast by Region (2023-2028)
12.1.2 Global Preventive Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preventive Vaccines Forecast by Type
12.7 Global Preventive Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Preventive Vaccines Product Offered
13.1.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Preventive Vaccines Product Offered
13.2.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 CSL Ltd
13.3.1 CSL Ltd Company Information
13.3.2 CSL Ltd Preventive Vaccines Product Offered
13.3.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Ltd Main Business Overview
13.3.5 CSL Ltd Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Preventive Vaccines Product Offered
13.4.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Preventive Vaccines Product Offered
13.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Preventive Vaccines Product Offered
13.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventive Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Preventive Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Preventive Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Preventive Vaccines Segment by Type
2.2.1 Intramuscular Injection
2.2.2 Nasal Spray
2.2.3 Intradermal Shot
2.3 Preventive Vaccines Sales by Type
2.3.1 Global Preventive Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Preventive Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Preventive Vaccines Sale Price by Type (2017-2022)
2.4 Preventive Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Preventive Vaccines Sales by Application
2.5.1 Global Preventive Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Preventive Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Preventive Vaccines Sale Price by Application (2017-2022)
3 GLOBAL PREVENTIVE VACCINES BY COMPANY
3.1 Global Preventive Vaccines Breakdown Data by Company
3.1.1 Global Preventive Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Preventive Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Preventive Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Preventive Vaccines Revenue by Company (2020-2022)
3.2.2 Global Preventive Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Preventive Vaccines Sale Price by Company
3.4 Key Manufacturers Preventive Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventive Vaccines Product Location Distribution
3.4.2 Players Preventive Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Preventive Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Preventive Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Preventive Vaccines Annual Revenue by Geographic Region
4.2 World Historic Preventive Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Preventive Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Preventive Vaccines Annual Revenue by Country/Region
4.3 Americas Preventive Vaccines Sales Growth
4.4 APAC Preventive Vaccines Sales Growth
4.5 Europe Preventive Vaccines Sales Growth
4.6 Middle East & Africa Preventive Vaccines Sales Growth
5 AMERICAS
5.1 Americas Preventive Vaccines Sales by Country
5.1.1 Americas Preventive Vaccines Sales by Country (2017-2022)
5.1.2 Americas Preventive Vaccines Revenue by Country (2017-2022)
5.2 Americas Preventive Vaccines Sales by Type
5.3 Americas Preventive Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventive Vaccines Sales by Region
6.1.1 APAC Preventive Vaccines Sales by Region (2017-2022)
6.1.2 APAC Preventive Vaccines Revenue by Region (2017-2022)
6.2 APAC Preventive Vaccines Sales by Type
6.3 APAC Preventive Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventive Vaccines by Country
7.1.1 Europe Preventive Vaccines Sales by Country (2017-2022)
7.1.2 Europe Preventive Vaccines Revenue by Country (2017-2022)
7.2 Europe Preventive Vaccines Sales by Type
7.3 Europe Preventive Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventive Vaccines by Country
8.1.1 Middle East & Africa Preventive Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Preventive Vaccines Sales by Type
8.3 Middle East & Africa Preventive Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventive Vaccines
10.3 Manufacturing Process Analysis of Preventive Vaccines
10.4 Industry Chain Structure of Preventive Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventive Vaccines Distributors
11.3 Preventive Vaccines Customer
12 WORLD FORECAST REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION
12.1 Global Preventive Vaccines Market Size Forecast by Region
12.1.1 Global Preventive Vaccines Forecast by Region (2023-2028)
12.1.2 Global Preventive Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preventive Vaccines Forecast by Type
12.7 Global Preventive Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Preventive Vaccines Product Offered
13.1.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Preventive Vaccines Product Offered
13.2.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 CSL Ltd
13.3.1 CSL Ltd Company Information
13.3.2 CSL Ltd Preventive Vaccines Product Offered
13.3.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Ltd Main Business Overview
13.3.5 CSL Ltd Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Preventive Vaccines Product Offered
13.4.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Preventive Vaccines Product Offered
13.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Preventive Vaccines Product Offered
13.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Preventive Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Preventive Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Nasal Spray
Table 5. Major Players of Intradermal Shot
Table 6. Global Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 7. Global Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Preventive Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Preventive Vaccines Sale Price by Type (2017-2022) & (USD/Doses)
Table 11. Global Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 12. Global Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Preventive Vaccines Revenue by Application (2017-2022)
Table 14. Global Preventive Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Preventive Vaccines Sale Price by Application (2017-2022) & (USD/Doses)
Table 16. Global Preventive Vaccines Sales by Company (2020-2022) & (K Doses)
Table 17. Global Preventive Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Preventive Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Preventive Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Preventive Vaccines Sale Price by Company (2020-2022) & (USD/Doses)
Table 21. Key Manufacturers Preventive Vaccines Producing Area Distribution and Sales Area
Table 22. Players Preventive Vaccines Products Offered
Table 23. Preventive Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Preventive Vaccines Sales by Geographic Region (2017-2022) & (K Doses)
Table 27. Global Preventive Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Preventive Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Preventive Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Preventive Vaccines Sales by Country/Region (2017-2022) & (K Doses)
Table 31. Global Preventive Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Preventive Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Preventive Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 35. Americas Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 39. Americas Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 41. Americas Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
Table 43. APAC Preventive Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Preventive Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Preventive Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 47. APAC Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 49. APAC Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 51. Europe Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 55. Europe Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 57. Europe Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 59. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 63. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 65. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Preventive Vaccines
Table 67. Key Market Challenges & Risks of Preventive Vaccines
Table 68. Key Industry Trends of Preventive Vaccines
Table 69. Preventive Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Preventive Vaccines Distributors List
Table 72. Preventive Vaccines Customer List
Table 73. Global Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 74. Global Preventive Vaccines Sales Market Forecast by Region
Table 75. Global Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Preventive Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 78. Americas Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 80. APAC Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Europe Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 84. Middle East & Africa Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Preventive Vaccines Sales Forecast by Type (2023-2028) & (K Doses)
Table 86. Global Preventive Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Preventive Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Preventive Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Preventive Vaccines Sales Forecast by Application (2023-2028) & (K Doses)
Table 90. Global Preventive Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Preventive Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Preventive Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sanofi Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Preventive Vaccines Product Offered
Table 95. Sanofi Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. AstraZeneca Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Preventive Vaccines Product Offered
Table 100. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. CSL Ltd Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. CSL Ltd Preventive Vaccines Product Offered
Table 105. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 106. CSL Ltd Main Business
Table 107. CSL Ltd Latest Developments
Table 108. Abbott Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Preventive Vaccines Product Offered
Table 110. Abbott Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 111. Abbott Main Business
Table 112. Abbott Latest Developments
Table 113. GlaxoSmithKline Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Preventive Vaccines Product Offered
Table 115. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 116. GlaxoSmithKline Main Business
Table 117. GlaxoSmithKline Latest Developments
Table 118. Serum Institute of India Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Serum Institute of India Preventive Vaccines Product Offered
Table 120. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 121. Serum Institute of India Main Business
Table 122. Serum Institute of India Latest Developments
Table 1. Preventive Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Preventive Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Nasal Spray
Table 5. Major Players of Intradermal Shot
Table 6. Global Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 7. Global Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Preventive Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Preventive Vaccines Sale Price by Type (2017-2022) & (USD/Doses)
Table 11. Global Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 12. Global Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Preventive Vaccines Revenue by Application (2017-2022)
Table 14. Global Preventive Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Preventive Vaccines Sale Price by Application (2017-2022) & (USD/Doses)
Table 16. Global Preventive Vaccines Sales by Company (2020-2022) & (K Doses)
Table 17. Global Preventive Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Preventive Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Preventive Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Preventive Vaccines Sale Price by Company (2020-2022) & (USD/Doses)
Table 21. Key Manufacturers Preventive Vaccines Producing Area Distribution and Sales Area
Table 22. Players Preventive Vaccines Products Offered
Table 23. Preventive Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Preventive Vaccines Sales by Geographic Region (2017-2022) & (K Doses)
Table 27. Global Preventive Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Preventive Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Preventive Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Preventive Vaccines Sales by Country/Region (2017-2022) & (K Doses)
Table 31. Global Preventive Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Preventive Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Preventive Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 35. Americas Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 39. Americas Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 41. Americas Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
Table 43. APAC Preventive Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Preventive Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Preventive Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 47. APAC Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 49. APAC Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 51. Europe Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 55. Europe Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 57. Europe Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 59. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 63. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 65. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Preventive Vaccines
Table 67. Key Market Challenges & Risks of Preventive Vaccines
Table 68. Key Industry Trends of Preventive Vaccines
Table 69. Preventive Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Preventive Vaccines Distributors List
Table 72. Preventive Vaccines Customer List
Table 73. Global Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 74. Global Preventive Vaccines Sales Market Forecast by Region
Table 75. Global Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Preventive Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 78. Americas Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 80. APAC Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Europe Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 84. Middle East & Africa Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Preventive Vaccines Sales Forecast by Type (2023-2028) & (K Doses)
Table 86. Global Preventive Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Preventive Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Preventive Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Preventive Vaccines Sales Forecast by Application (2023-2028) & (K Doses)
Table 90. Global Preventive Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Preventive Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Preventive Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sanofi Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Preventive Vaccines Product Offered
Table 95. Sanofi Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. AstraZeneca Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Preventive Vaccines Product Offered
Table 100. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. CSL Ltd Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. CSL Ltd Preventive Vaccines Product Offered
Table 105. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 106. CSL Ltd Main Business
Table 107. CSL Ltd Latest Developments
Table 108. Abbott Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Preventive Vaccines Product Offered
Table 110. Abbott Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 111. Abbott Main Business
Table 112. Abbott Latest Developments
Table 113. GlaxoSmithKline Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Preventive Vaccines Product Offered
Table 115. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 116. GlaxoSmithKline Main Business
Table 117. GlaxoSmithKline Latest Developments
Table 118. Serum Institute of India Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Serum Institute of India Preventive Vaccines Product Offered
Table 120. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 121. Serum Institute of India Main Business
Table 122. Serum Institute of India Latest Developments
LIST OF FIGURES
Figure 1. Picture of Preventive Vaccines
Figure 2. Preventive Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Vaccines Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Preventive Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Preventive Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intramuscular Injection
Figure 10. Product Picture of Nasal Spray
Figure 11. Product Picture of Intradermal Shot
Figure 12. Global Preventive Vaccines Sales Market Share by Type in 2021
Figure 13. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Preventive Vaccines Consumed in Hospital
Figure 15. Global Preventive Vaccines Market: Hospital (2017-2022) & (K Doses)
Figure 16. Preventive Vaccines Consumed in Clinic
Figure 17. Global Preventive Vaccines Market: Clinic (2017-2022) & (K Doses)
Figure 18. Preventive Vaccines Consumed in Other
Figure 19. Global Preventive Vaccines Market: Other (2017-2022) & (K Doses)
Figure 20. Global Preventive Vaccines Sales Market Share by Application (2017-2022)
Figure 21. Global Preventive Vaccines Revenue Market Share by Application in 2021
Figure 22. Preventive Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Preventive Vaccines Revenue Market Share by Company in 2021
Figure 24. Global Preventive Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Preventive Vaccines Revenue Market Share by Geographic Region in 2021
Figure 26. Global Preventive Vaccines Sales Market Share by Region (2017-2022)
Figure 27. Global Preventive Vaccines Revenue Market Share by Country/Region in 2021
Figure 28. Americas Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 29. Americas Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. APAC Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 31. APAC Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Europe Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 33. Europe Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 35. Middle East & Africa Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Americas Preventive Vaccines Sales Market Share by Country in 2021
Figure 37. Americas Preventive Vaccines Revenue Market Share by Country in 2021
Figure 38. United States Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Preventive Vaccines Sales Market Share by Region in 2021
Figure 43. APAC Preventive Vaccines Revenue Market Share by Regions in 2021
Figure 44. China Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Preventive Vaccines Sales Market Share by Country in 2021
Figure 51. Europe Preventive Vaccines Revenue Market Share by Country in 2021
Figure 52. Germany Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Preventive Vaccines Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Preventive Vaccines Revenue Market Share by Country in 2021
Figure 59. Egypt Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2021
Figure 65. Manufacturing Process Analysis of Preventive Vaccines
Figure 66. Industry Chain Structure of Preventive Vaccines
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Preventive Vaccines
Figure 2. Preventive Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Vaccines Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Preventive Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Preventive Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intramuscular Injection
Figure 10. Product Picture of Nasal Spray
Figure 11. Product Picture of Intradermal Shot
Figure 12. Global Preventive Vaccines Sales Market Share by Type in 2021
Figure 13. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Preventive Vaccines Consumed in Hospital
Figure 15. Global Preventive Vaccines Market: Hospital (2017-2022) & (K Doses)
Figure 16. Preventive Vaccines Consumed in Clinic
Figure 17. Global Preventive Vaccines Market: Clinic (2017-2022) & (K Doses)
Figure 18. Preventive Vaccines Consumed in Other
Figure 19. Global Preventive Vaccines Market: Other (2017-2022) & (K Doses)
Figure 20. Global Preventive Vaccines Sales Market Share by Application (2017-2022)
Figure 21. Global Preventive Vaccines Revenue Market Share by Application in 2021
Figure 22. Preventive Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Preventive Vaccines Revenue Market Share by Company in 2021
Figure 24. Global Preventive Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Preventive Vaccines Revenue Market Share by Geographic Region in 2021
Figure 26. Global Preventive Vaccines Sales Market Share by Region (2017-2022)
Figure 27. Global Preventive Vaccines Revenue Market Share by Country/Region in 2021
Figure 28. Americas Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 29. Americas Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. APAC Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 31. APAC Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Europe Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 33. Europe Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Preventive Vaccines Sales 2017-2022 (K Doses)
Figure 35. Middle East & Africa Preventive Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Americas Preventive Vaccines Sales Market Share by Country in 2021
Figure 37. Americas Preventive Vaccines Revenue Market Share by Country in 2021
Figure 38. United States Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Preventive Vaccines Sales Market Share by Region in 2021
Figure 43. APAC Preventive Vaccines Revenue Market Share by Regions in 2021
Figure 44. China Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Preventive Vaccines Sales Market Share by Country in 2021
Figure 51. Europe Preventive Vaccines Revenue Market Share by Country in 2021
Figure 52. Germany Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Preventive Vaccines Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Preventive Vaccines Revenue Market Share by Country in 2021
Figure 59. Egypt Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2021
Figure 65. Manufacturing Process Analysis of Preventive Vaccines
Figure 66. Industry Chain Structure of Preventive Vaccines
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
